Kasamatsu Toshio, Kohda Kohfuku
Faculty of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi, Nishitokyo-shi, Tokyo 202-8585, Japan.
Regul Toxicol Pharmacol. 2006 Oct;46(1):100-4. doi: 10.1016/j.yrtph.2006.05.011. Epub 2006 Jul 14.
Regulatory policies designed to reduce the health risk of environmental and/or synthetic chemicals generally aim for zero or negligible levels. Foods, on the other hand, especially those with a long history in the human diet, have been treated as essentially safe, even though they too contain various chemicals including nutrients. The recent debate on the presence in food of acrylamide, a possible human carcinogen, is likely to shake up the traditional paradigm held by regulatory agencies on chemical health risks. The current stance on the safety of acrylamide in food seems to be an extension of the traditional approach to assessment of environmental and/or synthetic chemicals. However, even foods which have long been a part of the human diet contain components that do not necessarily meet the safety margins applied to environmental and/or synthetic chemicals. In the future, a greater understanding of the effect of these agents on biological systems as well as the development of analytical methods for testing will result in many questions being raised concerning chemicals in foods, such as acrylamide which is under scrutiny today. Regulatory policies currently employ various standards for controlling chemical risk. These standards are dependent upon the labeling of the chemical in question, e.g., whether carcinogenic or non-carcinogenic, synthetic or natural, or whether a food or industrial chemical. Regardless of labeling, all chemicals to which we are exposed should be evaluated on an equal footing. Then, according to the level of the identified health risk, regulations could or could not be applied based on local circumstances, e.g., public acceptance, voluntary risk vs. involuntary risk, etc. In order to create a standardized system for chemical risk assessment, the introduction of uniform measures is essential. Loss of life expectancy (LLE) is one possible measure to assess chemical health risk. When LLE has been used, animal toxicity data have indicated that an ad libitum diet intake has considerably more impact on health risk than the acrylamide concentration of the ingested food. Reassessing the health effects of chemicals with a system of uniform measures could reveal many risks that need to be preferentially addressed above and beyond keeping minor toxicants to zero or negligible levels. Recognition of such risks may result in changes that conflict with existing regulations. In any case, whether consciously or unconsciously, people have always been exposed to a certain degree of chemical risk in their daily life. Based on the premise that the public can accept some degree of chemical risk in balance with other risks in their lives, regulatory bodies should be able to take a flexible and effective approach. In order to efficiently and comprehensively maximize the protection of our health against potential harm from chemicals using limited public resources, it is now time for regulatory agencies to restructure their policy frameworks across categories for controlling chemical health risks.
旨在降低环境化学品和/或合成化学品健康风险的监管政策通常目标是将其含量降至零或可忽略不计的水平。另一方面,食品,尤其是那些在人类饮食中有悠久历史的食品,即使它们同样含有包括营养成分在内的各种化学物质,也一直被视为基本安全。最近关于食品中丙烯酰胺(一种可能的人类致癌物)存在的争论,可能会撼动监管机构对化学品健康风险所持的传统范式。目前对食品中丙烯酰胺安全性的立场似乎是对评估环境化学品和/或合成化学品传统方法的延伸。然而,即使是长期以来一直是人类饮食一部分的食品,也含有一些不一定符合适用于环境化学品和/或合成化学品安全标准的成分。未来,对这些物质对生物系统影响的更深入了解以及检测分析方法的发展,将引发许多关于食品中化学品的问题,比如如今正在受到审查的丙烯酰胺。目前的监管政策采用各种标准来控制化学品风险。这些标准取决于所讨论化学品的标签,例如,是否致癌或非致癌、合成或天然,或者是食品化学品还是工业化学品。无论标签如何,我们接触到的所有化学品都应在平等基础上进行评估。然后,根据确定的健康风险水平,可根据当地情况(例如公众接受程度、自愿风险与非自愿风险等)决定是否应用相关法规。为了建立一个标准化的化学品风险评估体系,引入统一措施至关重要。预期寿命损失(LLE)是评估化学品健康风险的一种可能措施。当使用预期寿命损失时,动物毒性数据表明,随意饮食摄入量对健康风险的影响远大于所摄入食物中的丙烯酰胺浓度。用统一措施体系重新评估化学品的健康影响,可能会揭示许多除了将微量有毒物质降至零或可忽略不计水平之外还需要优先解决的风险。认识到这些风险可能会导致与现有法规相冲突的变化。无论如何,无论有意识还是无意识,人们在日常生活中一直都在接触一定程度的化学风险。基于公众能够接受一定程度化学风险并与生活中的其他风险相平衡这一前提,监管机构应该能够采取灵活有效的方法。为了利用有限的公共资源高效、全面地最大程度保护我们的健康免受化学品潜在危害,现在是监管机构重新构建其跨类别控制化学品健康风险的政策框架的时候了。